Circulating cholesterol as a modulator of risk for renal injury in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages 68-73

  Earle, Kenneth A ^a   Harry, Diane ^a   Zitouni, Karima ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Albuminuria; Diabetes mellitus; Hypercholesterolaemia; Hypertension; Race

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN; THIAZIDE DIURETIC AGENT;

ADULT; AFRICA; AGED; ALBUMINURIA; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIA; CAUCASIAN; COUGHING; CREATININE BLOOD LEVEL; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE; REMISSION; RISK FACTOR; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; URINARY EXCRETION;

AGED; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 37549072191     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.07.014     Document Type: Article

References (22)

1. Valmadrid C.T., Klein R., Moss S.E., and Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 16 (2000) 1093-1100
2. Parving H.H., Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arner P., et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 345 (2001) 870-878
3. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., and Holman R.R. Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes 55 (2006) 1832-1839
4. Kamanna V.S., Roh D.D., and Kirschenbaum M.A. Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus. Histol. Histopathol. 13 (1998) 169-179
5. Jiang T., Liebman T.E., Lucia M.S., Li J., and Levi M. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int. 68 (2005) 2608-2620
6. Hammad S.M., Hazen-Martin D.J., Sohn M., Eldridge L., Powell-Braxton L., Won W., et al. Nephropathy in a hypercholesterolemic mouse model with streptozotocin-induced diabetes. Kidney Blood Press Res. 26 (2003) 351-361
7. Dominguez J.H., Tang N., Xu W., Evan A.P., Siakotos A.N., Agarwal R., et al. Studies of renal injury III: lipid-induced nephropathy in type II diabetes. Kidney Int. 57 (2000) 92-104
8. Campese V.M., Nadim M.K., and Epstein M. Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective. J. Am. Soc. Nephrol. 16 (2005) S11-S17
9. Sarkar K., Sinha A.K., and Mehta J.L. The role of statins in endothelial dysfunction in hypertension. Curr. Opin. Cardiol. 21 (2006) 316-321
10. Earle K.A., Porter K.A., Ostberg J., and Yudkin J.S. Variation in the progression of diabetic nephropathy according to racial origin. Nephrol. Dial. Transplant 16 (2001) 286-290
11. Roest M., Banga J.D., Janssen W.M., Grobbee D.E., Sixma J.J., de Jong P.E., et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 103 (2001) 3057-3061
12. Hillege H.L., Janssen W.M., Bak A.A., Diercks G.F., Grobbee D.E., Crijns H.J., et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J. Intern. Med. 249 (2001) 519-526
13. Estacio R.O., Jeffers B.W., Gifford N., and Schrier R.W. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 23 (2000) B54-B64
14. Hovind P., Rossing P., Tarnow L., Smidt U.M., and Parving H.H. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int. 60 (2001) 277-283
15. Srinivasan S.R., Myers L., and Berenson G.S. Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study. Am. J. Hypertens. 13 (2000) 1274-1279
16. Summerson J.H., Bell R.A., and Konen J.C. Racial differences in the prevalence of microalbuminuria in hypertension. Am. J. Kidney Dis. 26 (1995) 577-579
17. Hebert L.A., Kusek J.W., Greene T., Agodoa L.Y., Jones C.A., Levey A.S., et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension 30 (1997) 428-435
18. Hirano T. Lipoprotein abnormalities in diabetic nephropathy. Kidney Int. Suppl. 71 (1999) S22-S24
19. Earle K.A., Mehrotra S., Dalton R.N., Denver E., and Swaminathan R. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with White origin. J. Am. Soc. Nephrol. 12 (2001) 2125-2130
20. Perkins B.A., Ficociello L.H., Silva K.H., Finkelstein D.M., Warram J.H., Krolewski A.S., et al. Regression of microalbuminuria in type 1 diabetes. N. Engl. J. Med. 348 (2003) 2285-2293
21. Colhoun H.M., Betteridge D.J., Durrington P.N., Hitman G.A., Neil H.A., Livingstone S.J., et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 (2004) 685-696
22. Ozsoy R.C., van der Steeg W.A., Kastelein J.J., Arisz L., and Koopman M.G. Dyslipidaemia as a predictor of progressive renal failure and the impact of treatment with atrorvastatin. Nephrol. Dial. Transplant 22 (2007) 1578-1586